HEADER TRANSCRIPTION 05-MAR-04 1SKX TITLE STRUCTURAL DISORDER IN THE COMPLEX OF HUMAN PXR AND THE MACROLIDE TITLE 2 ANTIBIOTIC RIFAMPICIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ORPHAN NUCLEAR RECEPTOR PXR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PXR LIGAND BINDING DOMAIN; RESIDUES 130-431; COMPND 5 SYNONYM: PREGNANE X RECEPTOR, ORPHAN NUCLEAR RECEPTOR PAR1, STEROID COMPND 6 AND XENOBIOTIC RECEPTOR, SXR; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1I2, PXR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: PRSETA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: BL21(DE3) KEYWDS PREGNANE X RECEPTOR, RIFAMPICIN, NUCLEAR RECEPTOR, LIGAND BINDING KEYWDS 2 DOMAIN, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR J.E.CHRENCIK,Y.XUE,J.O.ORANS,M.R.REDINBO REVDAT 4 23-AUG-23 1SKX 1 REMARK SEQADV REVDAT 3 24-FEB-09 1SKX 1 VERSN REVDAT 2 03-MAY-05 1SKX 1 JRNL REVDAT 1 08-MAR-05 1SKX 0 JRNL AUTH J.E.CHRENCIK,J.O.ORANS,L.B.MOORE,Y.XUE,L.PENG,J.L.COLLINS, JRNL AUTH 2 G.B.WISELY,M.H.LAMBERT,S.A.KLIEWER,M.R.REDINBO JRNL TITL STRUCTURAL DISORDER IN THE COMPLEX OF HUMAN PREGNANE X JRNL TITL 2 RECEPTOR AND THE MACROLIDE ANTIBIOTIC RIFAMPICIN JRNL REF MOL.ENDOCRINOL. V. 19 1125 2005 JRNL REFN ISSN 0888-8809 JRNL PMID 15705662 JRNL DOI 10.1210/ME.2004-0346 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 9358 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1421 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.90 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2180 REMARK 3 BIN FREE R VALUE : 0.2660 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 1421 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.036 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1994 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 51 REMARK 3 SOLVENT ATOMS : 93 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.27000 REMARK 3 B22 (A**2) : -4.27000 REMARK 3 B33 (A**2) : 8.53900 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.31 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.790 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.573 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.781 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.160 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.354 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : RIF_HICUP.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : RIF_HICUP.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1SKX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-MAR-04. REMARK 100 THE DEPOSITION ID IS D_1000021801. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-AUG-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : YALE MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : TRUNCATE, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : CCP4 (TRUNCATE) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9358 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 27.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1ILG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50MM IMIDIZOLE, 9% 2-PROPANOL, PH 7.2, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.75200 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 45.76850 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 45.76850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 64.12800 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 45.76850 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 45.76850 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 21.37600 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 45.76850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 45.76850 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 64.12800 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 45.76850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 45.76850 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 21.37600 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 42.75200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 119 REMARK 465 LYS A 120 REMARK 465 LYS A 121 REMARK 465 GLY A 122 REMARK 465 HIS A 123 REMARK 465 HIS A 124 REMARK 465 HIS A 125 REMARK 465 HIS A 126 REMARK 465 HIS A 127 REMARK 465 HIS A 128 REMARK 465 GLY A 129 REMARK 465 SER A 130 REMARK 465 GLU A 131 REMARK 465 ARG A 132 REMARK 465 THR A 133 REMARK 465 GLY A 134 REMARK 465 THR A 135 REMARK 465 GLN A 136 REMARK 465 PRO A 137 REMARK 465 LEU A 138 REMARK 465 GLY A 139 REMARK 465 VAL A 140 REMARK 465 GLN A 141 REMARK 465 GLY A 142 REMARK 465 LEU A 178 REMARK 465 SER A 179 REMARK 465 SER A 180 REMARK 465 GLY A 181 REMARK 465 CYS A 182 REMARK 465 GLU A 183 REMARK 465 LEU A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 SER A 187 REMARK 465 LEU A 188 REMARK 465 GLN A 189 REMARK 465 ALA A 190 REMARK 465 PRO A 191 REMARK 465 SER A 192 REMARK 465 ARG A 193 REMARK 465 GLU A 194 REMARK 465 GLU A 195 REMARK 465 ALA A 196 REMARK 465 ALA A 197 REMARK 465 LYS A 198 REMARK 465 TRP A 199 REMARK 465 SER A 200 REMARK 465 GLN A 201 REMARK 465 VAL A 202 REMARK 465 ARG A 203 REMARK 465 LYS A 204 REMARK 465 ASP A 205 REMARK 465 LEU A 206 REMARK 465 CYS A 207 REMARK 465 SER A 208 REMARK 465 LEU A 209 REMARK 465 ALA A 229 REMARK 465 ASP A 230 REMARK 465 SER A 231 REMARK 465 GLY A 232 REMARK 465 GLY A 233 REMARK 465 LYS A 234 REMARK 465 GLU A 235 REMARK 465 ASP A 310 REMARK 465 THR A 311 REMARK 465 ALA A 312 REMARK 465 GLY A 313 REMARK 465 GLY A 314 REMARK 465 PHE A 315 REMARK 465 GLN A 316 REMARK 465 GLN A 317 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 280 -65.42 -28.75 REMARK 500 PHE A 349 58.95 -97.06 REMARK 500 GLN A 358 47.64 -82.31 REMARK 500 PHE A 420 -27.08 -145.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 RFP A 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RFP A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ILG RELATED DB: PDB REMARK 900 APO PXR REMARK 900 RELATED ID: 1M13 RELATED DB: PDB REMARK 900 PXR-HYPERFORIN COMPLEX DBREF 1SKX A 130 431 UNP O75469 PXR_HUMAN 130 431 SEQADV 1SKX MET A 119 UNP O75469 INITIATING METHIONINE SEQADV 1SKX LYS A 120 UNP O75469 EXPRESSION TAG SEQADV 1SKX LYS A 121 UNP O75469 EXPRESSION TAG SEQADV 1SKX GLY A 122 UNP O75469 EXPRESSION TAG SEQADV 1SKX HIS A 123 UNP O75469 EXPRESSION TAG SEQADV 1SKX HIS A 124 UNP O75469 EXPRESSION TAG SEQADV 1SKX HIS A 125 UNP O75469 EXPRESSION TAG SEQADV 1SKX HIS A 126 UNP O75469 EXPRESSION TAG SEQADV 1SKX HIS A 127 UNP O75469 EXPRESSION TAG SEQADV 1SKX HIS A 128 UNP O75469 EXPRESSION TAG SEQADV 1SKX GLY A 129 UNP O75469 EXPRESSION TAG SEQRES 1 A 313 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER GLU SEQRES 2 A 313 ARG THR GLY THR GLN PRO LEU GLY VAL GLN GLY LEU THR SEQRES 3 A 313 GLU GLU GLN ARG MET MET ILE ARG GLU LEU MET ASP ALA SEQRES 4 A 313 GLN MET LYS THR PHE ASP THR THR PHE SER HIS PHE LYS SEQRES 5 A 313 ASN PHE ARG LEU PRO GLY VAL LEU SER SER GLY CYS GLU SEQRES 6 A 313 LEU PRO GLU SER LEU GLN ALA PRO SER ARG GLU GLU ALA SEQRES 7 A 313 ALA LYS TRP SER GLN VAL ARG LYS ASP LEU CYS SER LEU SEQRES 8 A 313 LYS VAL SER LEU GLN LEU ARG GLY GLU ASP GLY SER VAL SEQRES 9 A 313 TRP ASN TYR LYS PRO PRO ALA ASP SER GLY GLY LYS GLU SEQRES 10 A 313 ILE PHE SER LEU LEU PRO HIS MET ALA ASP MET SER THR SEQRES 11 A 313 TYR MET PHE LYS GLY ILE ILE SER PHE ALA LYS VAL ILE SEQRES 12 A 313 SER TYR PHE ARG ASP LEU PRO ILE GLU ASP GLN ILE SER SEQRES 13 A 313 LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS GLN LEU ARG SEQRES 14 A 313 PHE ASN THR VAL PHE ASN ALA GLU THR GLY THR TRP GLU SEQRES 15 A 313 CYS GLY ARG LEU SER TYR CYS LEU GLU ASP THR ALA GLY SEQRES 16 A 313 GLY PHE GLN GLN LEU LEU LEU GLU PRO MET LEU LYS PHE SEQRES 17 A 313 HIS TYR MET LEU LYS LYS LEU GLN LEU HIS GLU GLU GLU SEQRES 18 A 313 TYR VAL LEU MET GLN ALA ILE SER LEU PHE SER PRO ASP SEQRES 19 A 313 ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL ASP GLN LEU SEQRES 20 A 313 GLN GLU GLN PHE ALA ILE THR LEU LYS SER TYR ILE GLU SEQRES 21 A 313 CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE LEU PHE LEU SEQRES 22 A 313 LYS ILE MET ALA MET LEU THR GLU LEU ARG SER ILE ASN SEQRES 23 A 313 ALA GLN HIS THR GLN ARG LEU LEU ARG ILE GLN ASP ILE SEQRES 24 A 313 HIS PRO PHE ALA THR PRO LEU MET GLN GLU LEU PHE GLY SEQRES 25 A 313 ILE HET RFP A 1 51 HETNAM RFP RIFAMPICIN FORMUL 2 RFP C43 H58 N4 O12 FORMUL 3 HOH *93(H2 O) HELIX 1 1 THR A 144 PHE A 162 1 19 HELIX 2 2 LEU A 239 VAL A 260 1 22 HELIX 3 3 ILE A 261 ASP A 266 1 6 HELIX 4 4 PRO A 268 VAL A 291 1 24 HELIX 5 5 GLU A 321 LEU A 333 1 13 HELIX 6 6 HIS A 336 PHE A 349 1 14 HELIX 7 7 GLN A 358 ARG A 381 1 24 HELIX 8 8 GLN A 383 ARG A 387 5 5 HELIX 9 9 PHE A 388 HIS A 418 1 31 HELIX 10 10 THR A 422 GLY A 430 1 9 SHEET 1 A 5 VAL A 222 TYR A 225 0 SHEET 2 A 5 VAL A 211 ARG A 216 -1 N LEU A 213 O TYR A 225 SHEET 3 A 5 LEU A 304 LEU A 308 -1 O CYS A 307 N SER A 212 SHEET 4 A 5 THR A 298 CYS A 301 -1 N TRP A 299 O TYR A 306 SHEET 5 A 5 PHE A 292 ASN A 293 -1 N ASN A 293 O THR A 298 SITE 1 AC1 15 LYS A 210 VAL A 211 LEU A 240 MET A 243 SITE 2 AC1 15 SER A 247 PHE A 251 PHE A 281 CYS A 284 SITE 3 AC1 15 GLN A 285 TRP A 299 LEU A 308 MET A 323 SITE 4 AC1 15 HIS A 407 PHE A 420 HOH A 608 CRYST1 91.537 91.537 85.504 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010925 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010925 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011695 0.00000